Get the Stockscreener App
0.1401
0.92%
-0.0013
Endovia Health Sciences, Inc. stock is traded at $0.1401, with a volume of 249.16K.
It is down -0.92% in the last 24 hours and down -40.61% over the past month.
See More
Previous Close:
$0.1414
Open:
$0.1389
24h Volume:
249.16K
Relative Volume:
0.20
Market Cap:
$1.55M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-12.38%
1M Performance:
-40.61%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.1367
$0.16
52-Week Range:
$0.1367
$0.4599
Endovia Health Sciences, Inc. Stock (EDVA) Company Profile
Name
Endovia Health Sciences, Inc.
Sector
Industry
Phone
-
Address
-
Compare EDVA vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDVA
Endovia Health Sciences, Inc.
|
0.1401 | 1.55M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.38 | 128.85B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.63 | 94.87B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.99 | 82.36B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
849.57 | 53.43B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
371.40 | 42.01B | 5.76B | 514.49M | 1.10B | 4.4813 |
Endovia Health Sciences, Inc. Stock (EDVA) Latest News
Endovia Health Sciences Announces FDA Minor Use Determination for CannEpil® in Dogs With Bone Cancer Pain - Quiver Quantitative
A proposed treatment for dogs’ bone cancer pain qualifies to pursue conditional FDA approval - Stock Titan
Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026 - TradingView
Endovia Health Sciences Secures $1 Million Investment Commitment for CannEpil Development - Minichart
Endovia Health Sciences Secures $510,000 Convertible Note From C/M Capital, Part of $1 Million Commitment - TradingView
Endovia secures $1M minimum investment commitment - Stock Titan
Form PRE 14A ENDOVIA HEALTH SCIENCES For: 24 September By Investing.com - Investing.com Nigeria
Form PRE 14A ENDOVIA HEALTH SCIENCES For: 24 September By Investing.com - Investing.com Canada
Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On - Benzinga
Endovia Health Sciences Secures Initial Funding to Advance CannEpil Development - citybiz
Endovia Health Sciences Announces Closing of Initial Funding Tranche to Advance CannEpil® Development and Commercialization - Quiver Quantitative
A proposed law could give qualifying botanical drugs 12 years of market exclusivity. Endovia closes funding. - Stock Titan
EDVA PE Ratio & Valuation, Is EDVA Overvalued - Intellectia AI
EDVA Technical Analysis & Stock Price Forecast - Intellectia AI
EDVA Should I Buy - Intellectia AI
EDVA Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Splash Beverage H1 loss narrows 64%, rebrands as Endovia Health Sciences - scanx.trade
Endovia Health Sciences Welcomes Historic Shift in Federal - GlobeNewswire
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline - Yahoo Finance
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program - Yahoo Finance
Endovia Health Sciences, formerly Splash Beverage, Achieves - GlobeNewswire
Endovia's potential cannabinoid treatment for dogs with cancer pain enters FDA process - Stock Titan
EDVA Stock Quote Price and Forecast - CNN
Endovia Health Sciences, Inc. Balance Sheet – AMEX:EDVA - TradingView
Discontinued operations of Endovia Health Sciences, Inc. – AMEX:EDVA - TradingView
Endovia Health Sciences, Inc. Financial Statements – AMEX:EDVA - TradingView
EDVA Stock Price and Chart — AMEX:EDVA - TradingView
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - Yahoo Finance
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - GlobeNewswire
Splash Beverage Reports Second Quarter 2026 Results and - GlobeNewswire
Splash Beverage Group Reports Q2 2026 Results and Advances Transformation to Endovia Health Sciences - Quiver Quantitative
Splash Beverage shifts from alcoholic drinks to cannabinoid medicines for people and pets - stocktitan.net
Splash Beverage to rebrand as Endovia Health Sciences By Investing.com - Investing.com UK
Splash Beverage Group to Rebrand as Endovia Health Sciences - GlobeNewswire
Splash Beverage will officially become Endovia Health Sciences on August 21 (SBEV:NYSE) - Seeking Alpha
Splash Beverage to rebrand as Endovia Health Sciences - Investing.com
Splash Beverage Group to Rebrand as Endovia Health Sciences - Yahoo Finance UK
Splash Beverage to Rebrand as Endovia Health Sciences - Yahoo Finance
Splash Beverage plans shift from beverage business to cannabinoid health sciences - Stock Titan
Splash Beverage Group Announces Significant Balance Sheet - GlobeNewswire
Splash Beverage Group Receives NYSE American Acceptance of - GlobeNewswire
SBEV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Endovia Health Sciences, Inc. Stock (EDVA) Financials Data
There is no financial data for Endovia Health Sciences, Inc. (EDVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):